Embla Medical hf.

Equities

EMBLA

IS0000000040

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:43 2024-04-19 am EDT			5-day change	1st Jan Change
30.8 ^DKK	+4.41%		+2.67%	+12.20%

Apr. 08	Össur hf. will Change its Name to Embla Medical hf	CI
Mar. 13	Össur hf. Appoints Caroline Vagner Rosenstand to the Audit Committee	CI

Össur hf: Q2 2022 Results - Conference Call Thursday 21 July at 9:00 CEST

July 07, 2022 at 07:01 am EDT

Announcement no. 39/2022

7 July 2022

Conference call on Thursday 21 July at 9:00 CEST / 7:00 GMT / 3:00 ET

Össur will publish its financial results for Q2 2022 prior to market opening on Thursday 21 July. That same day at 9:00 CEST, Össur will host a conference call where Sveinn Sölvason, President and CEO, will present and discuss the results of the quarter. The conference call will be conducted in English.

A webcast can be followed on the Össur website: http://www.ossur.com/investors

To participate in the conference call, please click on this link: Össur Conference Call

Further information

Edda Lára Lúðvígsdóttir, Investor Relations Director, eludvigsdottir@ossur.com, +354 844 4759

Össur press releases by e-mail

If you wish to receive Össur press releases by e-mail, please register at http://www.ossur.com/investors

About Össur

Össur (Nasdaq Copenhagen: OSSR) is a global leader in non-invasive orthopaedics that helps people live a Life Without Limitations. A recognized "Technology Pioneer" with a rich 50-year history, Össur focuses on improving people's mobility through the delivery of innovative technologies in Prosthetics and Bracing & Supports. Significant investment in research and development have led to over 2,000 patents, award-winning designs, successful clinical outcomes, and consistently strong market positions. Össur is signatory to the UN Global Compact, UN Women's Empowerment Principles, contributes to the UN Sustainable Development Goals and became carbon neutral in 2021. Össur operates globally and employs around 4,000 employees. www.ossur.com

https://news.cision.com/ossur-hf-/r/ossur-hf--q2-2022-results---conference-call-thursday-21-july-at-9-00-cest,c3598335

Latest news about Embla Medical hf.

Össur hf. will Change its Name to Embla Medical hf	Apr. 08	CI
Össur hf. Appoints Caroline Vagner Rosenstand to the Audit Committee	Mar. 13	CI
Össur hf Establishes New Parent Organization to Be Named Embla Medical	Feb. 21	CI
Transcript : Össur hf., Q4 2023 Earnings Call, Jan 30, 2024	Jan. 30
Össur hf. Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 30	CI
Össur hf. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Jan. 30	CI
Össur hf. Provides Earnings Guidance for the Year 2024	Jan. 30	CI
Iceland's Össur to Purchase Fior & Gentz	Jan. 16	MT
Transcript : Fior & Gentz Gesellschaft Für Entwicklung Und Vertrieb Von Orthopädietechnischen Systemen Mbh, Össur hf. - M&A Call	Jan. 16
Össur hf. agreed to acquire Fior & Gentz Gesellschaft Für Entwicklung Und Vertrieb Von Orthopädietechnischen Systemen Mbh for ?120 million.	Jan. 15	CI
Transcript : Össur hf., Q3 2023 Earnings Call, Oct 24, 2023	23-10-24
Össur hf. Reaffirms Financial Guidance for the Year 2023	23-10-24	CI
Össur hf. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-24	CI
Transcript : Össur hf., Q2 2023 Earnings Call, Jul 25, 2023	23-07-25
Össur hf. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-25	CI
Össur hf. Announces Executive Changes	23-06-15	CI
Össur hf. Provides Earnings Guidance for the Year 2023	23-04-25	CI
Transcript : Ã–ssur hf., Q1 2023 Earnings Call, Apr 25, 2023	23-04-25
Össur hf. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Össur to Seek Acquisitions	23-03-30	CI
Transcript : Össur hf. - Analyst/Investor Day	23-03-30
Transcript : Össur hf., Q4 2022 Earnings Call, Jan 31, 2023	23-01-31
Össur hf. Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-31	CI
Össur hf. Provides Earnings Guidance for the Year 2023	23-01-31	CI
Össur hf. completed the acquisition of Proreva, Orthopedisch Maatwerk.	22-10-30	CI

Chart Embla Medical hf.

Duration

Period

More charts

Company Profile

Embla Medical hf, formerly Ossur hf, is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The Company's business activities are divided into three business segment: The Prosthetics, its product portfolio includes a range of lower and upper limb prosthetic components; The Bracing & Supports, which offers the Unloader One range of knee braces that relieve pain from knee osteoarthritis, as well as the Unloader Hip which is designed to reduce pain by optimizing load dispersion for patients suffering from mild and moderate osteoarthritis of the hip; and The Patient Care, which operates a network of Patient Care clinics around the world, with each one catering to individual patients and their needs.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-04-23 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Embla Medical hf.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

29.5 DKK

Average target price

34.36 DKK

Spread / Average Target

+16.47%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Prosthetics

	1st Jan change	Capi.
EMBLA MEDICAL HF.	+12.20%	1.8B
STRAUMANN HOLDING AG	-1.84%	23.52B
SONOVA HOLDING AG	-9.62%	16.27B
COCHLEAR LIMITED	+5.69%	13.45B
DEMANT A/S	+6.62%	9.68B
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.	-21.76%	2.01B
ANGELALIGN TECHNOLOGY INC.	+30.15%	1.62B
MODERN DENTAL GROUP LIMITED	+8.37%	570M
ANGEL ROBOTICS CO., LTD.	0.00%	524M
INTEGRUM AB	+29.68%	96.53M

Medical Prosthetics